Physician

Abhisek Swaika, MBBS

According to 2025 Medicare claims, Abhisek Swaika, MBBS (NPI: 1992010136) practices hematology/oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Queens, NY. This provider's primary affiliated billing organization is MEDICAL CARE OF QUEENS, PC (NPI: 1225683840; TIN: 474377679) and primary practice location at 11374-4510.

Swaika's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 240 traditional Medicare patients, billed 1,323 HCPCS/CPT codes, and received $115,654 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 570 prescription claims across 138 beneficiaries totaling $1,366,016 in drug costs, led by Tagrisso (Osimertinib Mesylate). 2021 DME data shows 19 claims. Open Payments data shows 7 records totaling $3,312. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,839 to $115,654. Similarly, Part D prescription costs have risen steadily, from $106,791 to $1,366,016. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	43	49	$3,839
2016	136	4,208	$49,801
2017	158	39,231	$561,467
2018	270	25,526	$281,014
2019	469	47,651	$551,583
2020	410	44,507	$948,661
2021	287	36,941	$880,790
2022	270	42,514	$993,273
2023	390	168,309	$3,621,909
2024	240	1,323	$115,654

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	48	131	$106,791
2016	26	88	$47,205
2017	61	248	$290,473
2018	57	314	$466,314
2019	79	461	$966,299
2020	106	760	$1,911,073
2021	101	819	$2,970,057
2022	130	852	$4,389,648
2023	141	562	$2,455,329
2024	138	570	$1,366,016

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	37	$3,210
2021	N/R	19	$2,094
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	29	29	$191
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	49	98	$156
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	166	689	$107
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	49	116	$76
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	130	312	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	19	570	$329,217
Brukinsa	Zanubrutinib	14	420	$103,821
Xtandi	Enzalutamide	11	330	$88,993
Eliquis	Apixaban	53	1,710	$33,171
Abiraterone Acetate	Abiraterone Acetate	14	540	$19,820

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$3,312	Exelixis Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abhisek Swaika, MBBS?

Tedicare shows public-source Medicare data for Abhisek Swaika, MBBS (NPI 1992010136), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhisek Swaika, MBBS have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abhisek Swaika, MBBS?

Abhisek Swaika, MBBS is linked to MEDICAL CARE OF QUEENS, PC (billing NPI 1225683840) in the available physician profile data.

Does Abhisek Swaika, MBBS have Open Payments data?

Abhisek Swaika, MBBS has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.